Development asset linked to Apogee Therapeutics in public FDA and regional records.
biotech · Atopic Dermatitis · Asthma · APGE
Apogee Therapeutics
Apogee Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- WALTHAM, MA, USA
- Founded
- 2022
- Employees
- 293
- Programs
- 8
- Drugs
- 2
- Patents
- 7
Apogee Therapeutics pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Apogee Therapeutics drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Apogee Therapeutics in public FDA and regional records.